![]() These RNA fragments can assist in the development and validation of RT-qPCR assays for the detection SARS-CoV-2. NIST rapidly developed a reference material consisting of synthetic fragments of the SARS-CoV-2 virus RNA, which is the target of molecular diagnostic tests. We immediately pivoted the NIST measurement infrastructure that has long supported biotechnology and biopharmaceutical manufacturing to address critical issues in the diagnosis and development of treatments for SARS-CoV-2. The National Institute of Standards and Technology is supporting the nation’s response to the COVID-19 pandemic with measurements, standards, data, and data science. We are offering a unit, free of charge, for evaluation in exchange for your feedback, which will help us improve and further develop the material. A new material from NIST can aid in the evaluation and development of RT-qPCR assays for SARS-CoV-2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |